Literature DB >> 26140716

The Dystrophin Complex: Structure, Function, and Implications for Therapy.

Quan Q Gao1, Elizabeth M McNally2.   

Abstract

The dystrophin complex stabilizes the plasma membrane of striated muscle cells. Loss of function mutations in the genes encoding dystrophin, or the associated proteins, trigger instability of the plasma membrane, and myofiber loss. Mutations in dystrophin have been extensively cataloged, providing remarkable structure-function correlation between predicted protein structure and clinical outcomes. These data have highlighted dystrophin regions necessary for in vivo function and fueled the design of viral vectors and now, exon skipping approaches for use in dystrophin restoration therapies. However, dystrophin restoration is likely more complex, owing to the role of the dystrophin complex as a broad cytoskeletal integrator. This review will focus on dystrophin restoration, with emphasis on the regions of dystrophin essential for interacting with its associated proteins and discuss the structural implications of these approaches.
© 2015 American Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26140716      PMCID: PMC4767260          DOI: 10.1002/cphy.c140048

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  167 in total

Review 1.  Filamins as integrators of cell mechanics and signalling.

Authors:  T P Stossel; J Condeelis; L Cooley; J H Hartwig; A Noegel; M Schleicher; S S Shapiro
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

2.  Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.

Authors:  Yuji Hara; Motoi Kanagawa; Stefan Kunz; Takako Yoshida-Moriguchi; Jakob S Satz; Yvonne M Kobayashi; Zihan Zhu; Steven J Burden; Michael B A Oldstone; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

3.  The N-terminal region of alpha-dystroglycan is an autonomous globular domain.

Authors:  A Brancaccio; T Schulthess; M Gesemann; J Engel
Journal:  Eur J Biochem       Date:  1997-05-15

Review 4.  Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactions.

Authors:  D J Blake; J M Tinsley; K E Davies; A E Knight; S J Winder; J Kendrick-Jones
Journal:  Trends Biochem Sci       Date:  1995-04       Impact factor: 13.807

5.  Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.

Authors:  Michelle H Kim; Danielle I Kay; Renuka T Rudra; Bo Ming Chen; Nigel Hsu; Yasuhiro Izumiya; Leonel Martinez; Melissa J Spencer; Kenneth Walsh; Alan D Grinnell; Rachelle H Crosbie
Journal:  Hum Mol Genet       Date:  2011-01-18       Impact factor: 6.150

6.  Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.

Authors:  Simanti Bhattacharya; Amit Das; Semanti Ghosh; Rakhi Dasgupta; Angshuman Bagchi
Journal:  Gene       Date:  2013-12-18       Impact factor: 3.688

7.  Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.

Authors:  Cheryl Longman; Martin Brockington; Silvia Torelli; Cecilia Jimenez-Mallebrera; Colin Kennedy; Nofal Khalil; Lucy Feng; Ravindra K Saran; Thomas Voit; Luciano Merlini; Caroline A Sewry; Susan C Brown; Francesco Muntoni
Journal:  Hum Mol Genet       Date:  2003-09-09       Impact factor: 6.150

8.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  Third International Workshop for Glycosylation Defects in Muscular Dystrophies, 18-19 April 2013, Charlotte, USA.

Authors:  Anthony Blaeser; Susan Sparks; Susan C Brown; Kevin Campbell; Qi Lu
Journal:  Brain Pathol       Date:  2014-03-03       Impact factor: 6.508

10.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

View more
  102 in total

1.  The Sex Chromosome Hypothesis of Schizophrenia: Alive, Dead, or Forgotten? A Commentary and Review.

Authors:  William K Bache; Lynn E DeLisi
Journal:  Mol Neuropsychiatry       Date:  2018-08-20

Review 2.  Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine.

Authors:  Nalinda B Wasala; Shi-Jie Chen; Dongsheng Duan
Journal:  Expert Opin Drug Discov       Date:  2020-01-30       Impact factor: 6.098

Review 3.  Gene Editing and Gene-Based Therapeutics for Cardiomyopathies.

Authors:  Joyce C Ohiri; Elizabeth M McNally
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

4.  Myocyte-derived Myomaker expression is required for regenerative fusion but exacerbates membrane instability in dystrophic myofibers.

Authors:  Michael J Petrany; Taejeong Song; Sakthivel Sadayappan; Douglas P Millay
Journal:  JCI Insight       Date:  2020-05-07

5.  β1 Syntrophin Supports Autophagy Initiation and Protects against Cerulein-Induced Acute Pancreatitis.

Authors:  Risheng Ye; Toshiharu Onodera; Pierre-Gilles Blanchard; Christine M Kusminski; Victoria Esser; Rolf A Brekken; Philipp E Scherer
Journal:  Am J Pathol       Date:  2019-01-14       Impact factor: 4.307

6.  Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca2+ cycling in vivo.

Authors:  Michelle L Law; Kurt W Prins; Megan E Olander; Joseph M Metzger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-17       Impact factor: 4.733

7.  Alterations in the muscle force transfer apparatus in aged rats during unloading and reloading: impact of microRNA-31.

Authors:  David C Hughes; George R Marcotte; Leslie M Baehr; Daniel W D West; Andrea G Marshall; Scott M Ebert; Arik Davidyan; Christopher M Adams; Sue C Bodine; Keith Baar
Journal:  J Physiol       Date:  2018-07       Impact factor: 5.182

8.  Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment.

Authors:  Xu Liu; Yashuo Wang; Jennifer S Gutierrez; Jesse M Damsker; Kanneboyina Nagaraju; Eric P Hoffman; Eric A Ortlund
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

9.  Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect.

Authors:  Eda Sun; Erdal Karaoz
Journal:  Am J Stem Cells       Date:  2020-08-25

Review 10.  The Role of Exercise and TFAM in Preventing Skeletal Muscle Atrophy.

Authors:  Nicholas T Theilen; George H Kunkel; Suresh C Tyagi
Journal:  J Cell Physiol       Date:  2017-04-12       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.